Skip to main content
Premium Trial:

Request an Annual Quote

BBSRC, UK Partners Launch Start-up Home

NEW YORK (GenomeWeb News) – The UK government's bioscience funding arm and regional development agencies in Norwich are building a new £5 million ($8.1 million) facility at the Norwich Research Park (NRP) that will provide lab space that researchers can use to translate their discoveries into commercially viable technologies.

The Biotechnology and Biological Sciences Research Council (BBSRC) will contribute the land and buildings to host the new facilities, along with £500,000.

The East of England Development Agency will chip in £1.4 million, the Greater Norwich Development Partnership will add £1 million, and the University of East Anglia will chip in £500,000. The remainder of the funding will come from other NRP partners.

The NRP includes several partners, including the University of East Anglia (UAE), Norfolk and Norwich University Hospital, and four research centers, including The Genome Analysis Centre, the Institute of Food Research, the John Innes Centre, and the Institute of Food Research (IFR).

The facility will be managed by the BBSRC, the IFR, and the UAE, as well as a new joint venture company called Colney Innovations (CIL).

"This new facility will play a key role in helping our scientists, and others, to translate their excellent science into products, services, advice, and jobs to benefit the economy and people of the UK," BBSRC's Chief Executive, Douglas Kell, said in a statement.

"The office and laboratory suites will provide unrivalled facilities for new and expanding research businesses attracted to the cluster of science facilities at the Norwich Research Park," BBSRC's Director of Finance and CIL's Director David Parfrey added.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.